In the general news, Turkey shot down a Russian bomber jet that crossed into its airspace from Syria. In the U.S., gunmen fired on black protestors in Minneapolis, and a deranged man killed several people at a Planned Parenthood center in Colorado, as Thanksgiving passed without any ISIS attacks.
In healthcare business news, Pfizer (PFE) and Allergan (AGN) agreed to a $150 Billion M&A merger and become another inversion deal to dodge U.S. taxes. Also, Amgen (AMGN) is embracing the biosimilar threat by pursuing its own biosimilar drug to compete with AbbVie’s (ABBV) Humira.
On the data front, questions over the safety of ADHD drugs, such as Ritalin, on children were raised again.
From the FDA, Bristol-Myers Squibb’s (BMY) Opdivo was approved for kidney cancer. Lastly, Eli Lilly’s (LLY) Potrazza was approved for lung cancer.